<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04543149</url>
  </required_header>
  <id_info>
    <org_study_id>Granulomatous mastitis cell</org_study_id>
    <nct_id>NCT04543149</nct_id>
  </id_info>
  <brief_title>Immune Cells in Patients With Granulomatous Mastitis</brief_title>
  <official_title>Evaluation of Immune Cells in Patients With Granulomatous Mastitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Granulomatous mastitis is a rare, chronic, benign inflammatory disease of the breast that&#xD;
      plays a role in many varying etiologies, including infectious and non-infectious causes.&#xD;
      Etiological reasons were examined in various studies, but neither etiology nor definite&#xD;
      criteria for diagnosis were found. Our aim in this study is to examine the role of&#xD;
      immunophenotyping in differentiating the etiology of granulomatous mastitis and using it as a&#xD;
      prognostic marker.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Granulomatous mastitis is a rare, chronic, benign inflammatory disease of the breast that&#xD;
      plays a role in many varying aetiology, including infectious and non-infectious causes. This&#xD;
      disease can clinically and radiographically mimic breast cancer, which can pose a diagnostic&#xD;
      challenge as well as concern during evaluation. A nonspecific inflammatory response,&#xD;
      'granuloma' is defined as necrosis or infiltration of other inflammatory leukocytes, with or&#xD;
      without mononuclear phagocyte collection. It is thought to be caused by infectious agents or&#xD;
      foreign substances that activate the immune system, leading to granuloma formation. Some of&#xD;
      the known inflammatory etiologies of granulomatous mastitis are autoimmune diseases such as&#xD;
      tuberculosis (most commonly caused by Mycobacterium tuberculosis), sarcoidosis, fungal&#xD;
      infection and granulomatosis with polyangiitis and giant cell arteritis. These diseases&#xD;
      cannot be distinguished clinically, pathologically, and radiographically from idiopathic&#xD;
      granulomatous mastitis.In this study, we aimed to investigate lymphocyte subtypes in patients&#xD;
      with granulomatous mastitis and to evaluate the differences in cell populations and its&#xD;
      usability as a predictive marker in diagnosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Actual">October 10, 2020</completion_date>
  <primary_completion_date type="Actual">October 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate T cell subsets and monocyte ratio</measure>
    <time_frame>3 months</time_frame>
    <description>CD3 (+) lymphocytes, CD4 (+) lymphocytes, CD 8 (+) lymphocytes, CD 3(-)/CD16 (+) NK cell ratio, CD14 (+) lymphocytes, and HLA-DR positivity on CD14 (+) cells</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">35</enrollment>
  <condition>Granulomatous Mastitis</condition>
  <arm_group>
    <arm_group_label>Case</arm_group_label>
    <description>Patients with idiopathic granulomatous mastitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Healthy volunteers</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Flow cytometric immunophenotyping</intervention_name>
    <description>To evaluate T cell subsets and monocyte</description>
    <arm_group_label>Case</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        In case group patients with granulomatous mastitis will be included to the study. During&#xD;
        diagnasis if the patient is diagnosed with tuberculosis, she will be excluded from the&#xD;
        study.&#xD;
&#xD;
        Also healty volunteers who don't have breast lesions are control group.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with granulomatous mastitis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cancer Patients&#xD;
&#xD;
          -  Patients with known immunodeficiency&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Patient diagnosed with tuberculosis&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Granulomatous mastitis is observed in female patients.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ufuk Oguz Idiz, Assoc.Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istanbul Training and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Istanbul Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34371</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Barreto DS, Sedgwick EL, Nagi CS, Benveniste AP. Granulomatous mastitis: etiology, imaging, pathology, treatment, and clinical findings. Breast Cancer Res Treat. 2018 Oct;171(3):527-534. doi: 10.1007/s10549-018-4870-3. Epub 2018 Jul 3. Review.</citation>
    <PMID>29971624</PMID>
  </reference>
  <reference>
    <citation>Skandarajah A, Marley L. Idiopathic granulomatous mastitis: a medical or surgical disease of the breast? ANZ J Surg. 2015 Dec;85(12):979-82. doi: 10.1111/ans.12929. Epub 2014 Nov 26.</citation>
    <PMID>25424519</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>September 3, 2020</study_first_submitted>
  <study_first_submitted_qc>September 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 9, 2020</study_first_posted>
  <last_update_submitted>January 11, 2021</last_update_submitted>
  <last_update_submitted_qc>January 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Ufuk Oguz Idiz</investigator_full_name>
    <investigator_title>Assoc. Prof. MD</investigator_title>
  </responsible_party>
  <keyword>Mastitis</keyword>
  <keyword>immunophenotyping</keyword>
  <keyword>Flow-cytometry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mastitis</mesh_term>
    <mesh_term>Granulomatous Mastitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

